Portfolio Holdings Detail for ISIN IE00B3ZW0K18
Stock Name / FundiShares S&P 500 EUR Hedged UCITS ETF (Acc)
IssuerBlackrock
Entity holding fund iShares V Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF TickerIBCF(EUR) F
ETF TickerIUES.AS(EUR) CXE
ETF TickerIUSE.L(EUR) CXE
ETF TickerIUSE.MI(EUR) CXE
ETF TickerIUSEz(EUR) CXE
ETF TickerIUSE(EUR) ETF Plus

Holdings detail for CRL

Stock NameCreightons Plc
TickerCRL(GBX) LSE
TYPECommon Stock
CountryUK
ISINGB0002341666
LEI213800WROWAJUBGSAJ57

Show aggregate CRL holdings

News associated with CRL

Charles River Laboratories International (NYSE:CRL) Downgraded to “Buy” Rating by Wall Street Zen
Wall Street Zen lowered shares of Charles River Laboratories International (NYSE:CRL – Free Report) from a strong-buy rating to a buy rating in a report issued on Sunday morning. Several other research firms also recently issued reports on CRL. Evercore ISI lifted their price target on Charles River Laboratories International from $180.00 to $190.00 and […] - 2025-09-22 03:13:04
Charles River CFO Flavia Pease To Step Down; Michael Knell Appointed Interim CFO
(RTTNews) - Charles River Laboratories International, Inc. (CRL) announced Tuesday that Flavia H. Pease, corporate executive vice president and chief financial officer, has resigned effective September 29, 2025, to pursue another opportunity. - 2025-09-16 08:28:15
Brokerages Set Charles River Laboratories International, Inc. (NYSE:CRL) PT at $175.69
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has received a consensus rating of “Hold” from the fifteen research firms that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, nine have given a hold recommendation and five have given a buy recommendation to […] - 2025-08-29 04:49:03
Wall Street Zen Downgrades Charles River Laboratories International (NYSE:CRL) to Buy
Charles River Laboratories International (NYSE:CRL – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Sunday. CRL has been the topic of a number of other reports. Robert W. Baird upped their price objective on Charles […] - 2025-08-19 02:50:57
Maryland State Retirement & Pension System Reduces Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Maryland State Retirement & Pension System lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 18.2% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,387 shares of the medical research company’s stock after […] - 2025-08-17 05:17:00
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Acquired by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. boosted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 577,322 shares of the medical research company’s stock after purchasing an additional 24,347 […] - 2025-08-13 05:42:56
Federated Hermes Inc. Lowers Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Federated Hermes Inc. cut its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 90.6% in the first quarter, Holdings Channel reports. The fund owned 225 shares of the medical research company’s stock after selling 2,172 shares during the quarter. Federated Hermes Inc.’s holdings in Charles River Laboratories International were worth $34,000 […] - 2025-08-12 05:06:53
Analysts Expect 10% Gains Ahead For The Holdings of SPUS
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-11 10:38:26
Kestra Private Wealth Services LLC Sells 115 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Kestra Private Wealth Services LLC lowered its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.6% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,929 shares of the medical research company’s stock after selling 115 […] - 2025-07-28 05:24:49
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Mutual of America Capital Management LLC
Mutual of America Capital Management LLC trimmed its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 2.9% in the first quarter, HoldingsChannel reports. The institutional investor owned 5,938 shares of the medical research company’s stock after selling 179 shares during the period. Mutual of America Capital Management LLC’s holdings […] - 2025-07-22 07:06:50
Arizona State Retirement System Sells 336 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Arizona State Retirement System decreased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 2.2% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 14,659 shares of the medical research company’s stock after selling 336 shares during the quarter. Arizona […] - 2025-07-18 05:10:58
Nisa Investment Advisors LLC Decreases Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Nisa Investment Advisors LLC reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 23.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,737 shares of the medical research company’s stock after selling 1,417 shares during […] - 2025-07-16 05:44:56
Brown Advisory Inc. Has $334,000 Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Brown Advisory Inc. lowered its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 84.9% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,219 shares of the medical research company’s stock after selling 12,506 shares during the period. Brown Advisory […] - 2025-07-16 04:56:59
Teacher Retirement System of Texas Takes $1.23 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Teacher Retirement System of Texas acquired a new stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) in the 1st quarter, Holdings Channel.com reports. The institutional investor acquired 8,180 shares of the medical research company’s stock, valued at approximately $1,231,000. Several other hedge funds also recently modified their holdings of the stock. Aaron […] - 2025-07-13 06:14:56
Charles River Laboratories International Reaches Analyst Target Price
In recent trading, shares of Charles River Laboratories International Inc. (Symbol: CRL) have crossed above the average analyst 12-month target price of $158.64, changing hands for $158.97/share. When a stock reaches the target an analyst has set, the analyst logically has two w - 2025-07-10 07:56:40
Charles River Laboratories International, Inc. (NYSE:CRL) Given Average Recommendation of “Hold” by Analysts
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has received an average rating of “Hold” from the sixteen ratings firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, eleven have assigned a hold recommendation and four have assigned a buy recommendation to the company. […] - 2025-07-07 04:26:46
New York State Teachers Retirement System Sells 4,446 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
New York State Teachers Retirement System lessened its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 9.8% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 40,784 shares of the medical research company’s stock after selling 4,446 shares […] - 2025-07-06 07:56:57
Sequoia Financial Advisors LLC Has $264,000 Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Sequoia Financial Advisors LLC reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 10.6% in the first quarter, HoldingsChannel.com reports. The fund owned 1,755 shares of the medical research company’s stock after selling 207 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Charles River Laboratories International […] - 2025-07-04 04:45:03
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,723 shares of the medical research company’s stock after selling 247 shares during the period. […] - 2025-07-03 04:26:50
Bessemer Group Inc. Sells 16,538 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Bessemer Group Inc. trimmed its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 70.5% during the first quarter, HoldingsChannel.com reports. The fund owned 6,935 shares of the medical research company’s stock after selling 16,538 shares during the quarter. Bessemer Group Inc.’s holdings in Charles River Laboratories International were worth $1,044,000 at […] - 2025-07-01 05:46:49
Asset Management One Co. Ltd. Sells 17,428 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Asset Management One Co. Ltd. lessened its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 92.1% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,490 shares of the medical research company’s stock after selling 17,428 shares during the […] - 2025-07-01 04:54:50
Congress Trade: Representative Jefferson Shreve Just Disclosed New Stock Trades
Representative Jefferson Shreve just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Jefferson Shreve and other politicians. - 2025-06-23 10:13:39
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Purchased by Blue Trust Inc.
Blue Trust Inc. grew its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 60.1% in the 1st quarter, HoldingsChannel.com reports. The fund owned 2,407 shares of the medical research company’s stock after acquiring an additional 904 shares during the period. Blue Trust Inc.’s holdings in Charles River Laboratories International […] - 2025-06-23 06:18:50
Yousif Capital Management LLC Has $856,000 Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Yousif Capital Management LLC lowered its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.6% in the first quarter, Holdings Channel.com reports. The firm owned 5,687 shares of the medical research company’s stock after selling 215 shares during the period. Yousif Capital Management LLC’s holdings in Charles River Laboratories […] - 2025-06-20 04:32:47
Tuesday Sector Laggards: Healthcare, Technology & Communications
The worst performing sector as of midday Tuesday is the Healthcare sector, showing a 1.4% loss. Within the sector, Charles River Laboratories International Inc. (Symbol: CRL) and Align Technology Inc (Symbol: ALGN) are two large stocks that are lagging, showing a loss of 4.4% an - 2025-06-17 15:32:11
Fifth Third Bancorp Lowers Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Fifth Third Bancorp lowered its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 18.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,747 shares of the medical research company’s stock after selling 2,030 shares during the […] - 2025-06-16 05:32:50
Handelsbanken Fonder AB Has $1.74 Million Stake in Charles River Laboratories International, Inc. (NYSE:CRL)
Handelsbanken Fonder AB reduced its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,537 shares of the medical research company’s stock after selling 900 shares during the […] - 2025-06-15 06:40:51
Congress Asset Management Co. Sells 1,482 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Congress Asset Management Co. lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 34.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,879 shares of the medical research company’s stock after selling 1,482 shares during […] - 2025-06-10 05:04:52
Rhumbline Advisers Has $13.06 Million Stake in Charles River Laboratories International, Inc. (NYSE:CRL)
Rhumbline Advisers boosted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.1% in the first quarter, HoldingsChannel reports. The firm owned 86,730 shares of the medical research company’s stock after acquiring an additional 3,405 shares during the period. Rhumbline Advisers’ holdings in Charles River Laboratories International were worth […] - 2025-06-09 06:02:56
Universal Beteiligungs und Servicegesellschaft mbH Invests $3.58 Million in Charles River Laboratories International, Inc. (NYSE:CRL)
Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 19,410 shares of the medical research company’s stock, valued at approximately $3,583,000. A number of other […] - 2025-06-02 05:58:52

iShares S&P 500 EUR Hedged UCITS ETF (Acc) CRL holdings

DateNumber of CRL Shares HeldBase Market Value of CRL SharesLocal Market Value of CRL SharesChange in CRL Shares HeldChange in CRL Base ValueCurrent Price per CRL Share HeldPrevious Price per CRL Share Held
2025-12-16 (Tuesday)7,998CRL holding increased by 66USD 1,326,567CRL holding decreased by -9650USD 1,326,56766USD -9,650 USD 165.862 USD 168.459
2025-12-15 (Monday)7,932CRL holding increased by 22USD 1,336,217CRL holding increased by 35482USD 1,336,21722USD 35,482 USD 168.459 USD 164.442
2025-12-12 (Friday)7,910CRL holding increased by 22USD 1,300,735CRL holding decreased by -3734USD 1,300,73522USD -3,734 USD 164.442 USD 165.374
2025-12-11 (Thursday)7,888CRL holding increased by 22USD 1,304,469CRL holding decreased by -12049USD 1,304,46922USD -12,049 USD 165.374 USD 167.368
2025-12-10 (Wednesday)7,866CRL holding increased by 22USD 1,316,518CRL holding increased by 61977USD 1,316,51822USD 61,977 USD 167.368 USD 159.936
2025-12-09 (Tuesday)7,844CRL holding increased by 11USD 1,254,541CRL holding decreased by -6286USD 1,254,54111USD -6,286 USD 159.936 USD 160.963
2025-12-08 (Monday)7,833USD 1,260,827CRL holding increased by 21387USD 1,260,8270USD 21,387 USD 160.963 USD 158.233
2025-12-05 (Friday)7,833USD 1,239,440CRL holding increased by 4519USD 1,239,4400USD 4,519 USD 158.233 USD 157.656
2025-12-04 (Thursday)7,833USD 1,234,921CRL holding decreased by -5503USD 1,234,9210USD -5,503 USD 157.656 USD 158.359
2025-12-03 (Wednesday)7,833USD 1,240,424CRL holding increased by 61003USD 1,240,4240USD 61,003 USD 158.359 USD 150.571
2025-12-02 (Tuesday)7,833CRL holding increased by 22USD 1,179,421CRL holding decreased by -3244USD 1,179,42122USD -3,244 USD 150.571 USD 151.41
2025-12-01 (Monday)7,811CRL holding increased by 55USD 1,182,665CRL holding decreased by -7851USD 1,182,66555USD -7,851 USD 151.41 USD 153.496
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CRL by Blackrock for IE00B3ZW0K18

Show aggregate share trades of CRL

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-16BUY66198.320194.503 194.885GBX 12,862 146.24
2025-12-15BUY22200.510195.100 195.641GBX 4,304 146.15
2025-12-12BUY22195.360192.140 192.462GBX 4,234 146.07
2025-12-11BUY22196.380192.375 192.776GBX 4,241 145.99
2025-12-10BUY22194.960186.645 187.477GBX 4,124 145.91
2025-12-09BUY11191.340185.930 186.471GBX 2,051 145.85
2025-12-02BUY22177.010172.950 173.356GBX 3,814 145.60
2025-12-01BUY55180.950175.710 176.234GBX 9,693 145.58
2025-11-28BUY11178.530176.930 177.090GBX 1,948 145.55
2025-11-24SELL-11171.720167.450 167.877GBX -1,847 145.42 Loss of -247 on sale
2025-11-21BUY11172.390157.490 158.980GBX 1,749 145.42
2025-11-19SELL-33161.955156.790 157.306GBX -5,191 145.47 Loss of -391 on sale
2025-11-18SELL-44164.335160.490 160.875GBX -7,078 145.49 Loss of -677 on sale
2025-11-17SELL-22169.995162.720 163.448GBX -3,596 145.51 Loss of -395 on sale
2025-11-07SELL-22171.500165.740 166.316GBX -3,659 145.48 Loss of -458 on sale
2025-11-05SELL-77170.140160.010 161.023GBX -12,399 145.47 Loss of -1,198 on sale
2025-10-28BUY11187.930193.470 192.916GBX 2,122 145.16
2025-10-14SELL-66170.130172.410 172.182GBX -11,364 144.52 Loss of -1,826 on sale
2025-10-02BUY22175.360178.190 177.907GBX 3,914 144.44
2025-09-30SELL-22156.460156.790 156.757GBX -3,449 144.49 Loss of -270 on sale
2025-09-16BUY11151.600152.930 152.797GBX 1,681 145.02
2025-08-21BUY11154.540158.290 157.915GBX 1,737 145.14
2025-08-20SELL-22159.580159.620 159.616GBX -3,512 145.18 Loss of -318 on sale
2025-08-13BUY22155.000155.430 155.387GBX 3,419 145.31
2025-08-12BUY11152.750154.010 153.884GBX 1,693 145.39
2025-08-08SELL-11148.740152.130 151.791GBX -1,670 145.59 Loss of -68 on sale
2025-08-05BUY22167.490168.330 168.246GBX 3,701 145.68
2025-08-04SELL-44167.920168.610 168.541GBX -7,416 145.68 Loss of -1,006 on sale
2025-08-01SELL-11166.910167.800 167.711GBX -1,845 145.69 Loss of -242 on sale
2025-07-31BUY33169.640176.150 175.499GBX 5,791 145.68
2025-07-30BUY11176.190180.020 179.637GBX 1,976 145.63
2025-07-18SELL-33154.480158.180 157.810GBX -5,208 145.78 Loss of -397 on sale
2025-07-16SELL-22154.940155.570 155.507GBX -3,421 145.92 Loss of -211 on sale
2025-07-10BUY11163.660168.120 167.674GBX 1,844 146.16
2025-07-07BUY22153.900156.720 156.438GBX 3,442 146.39
2025-07-02BUY11157.490158.380 158.291GBX 1,741 146.63
2025-06-24BUY22148.400149.680 149.552GBX 3,290 147.21
2025-06-23BUY11147.380148.320 148.226GBX 1,630 147.34
2025-06-18BUY11145.290147.100 146.919GBX 1,616 147.76
2025-06-17BUY11145.050150.540 149.991GBX 1,650 147.91
2025-06-05SELL-22141.200144.880 144.512GBX -3,179 148.99 Profit of 98 on sale
2025-06-03BUY22138.490139.730 139.606GBX 3,071 149.36
2025-05-28BUY121136.250138.890 138.626GBX 16,774 150.26
2025-05-27BUY33138.650140.650 140.450GBX 4,635 150.47
2025-05-22SELL-11135.600136.260 136.194GBX -1,498 151.18 Profit of 165 on sale
2025-05-21SELL-11134.980141.710 141.037GBX -1,551 151.43 Profit of 114 on sale
2025-05-20SELL-22143.530143.820 143.791GBX -3,163 151.62 Profit of 172 on sale
2025-05-19SELL-22141.380141.500 141.488GBX -3,113 151.83 Profit of 228 on sale
2025-05-15BUY11138.890139.380 139.331GBX 1,533 152.26
2025-05-14BUY22138.950146.430 145.682GBX 3,205 152.50
2025-05-13BUY33144.020145.640 145.478GBX 4,801 152.69
2025-05-12BUY66143.080147.640 147.184GBX 9,714 152.89
2025-05-09BUY33138.790143.460 142.993GBX 4,719 153.14
2025-05-02BUY11118.460121.810 121.475GBX 1,336 154.97
2025-04-28BUY11115.080117.160 116.952GBX 1,286 156.86
2025-04-25SELL-11114.660115.250 115.191GBX -1,267 157.37 Profit of 464 on sale
2025-04-24BUY33115.760115.940 115.922GBX 3,825 157.89
2025-04-23BUY11109.000116.060 115.354GBX 1,269 158.47
2025-04-22BUY11106.890107.290 107.250GBX 1,180 159.08
2025-04-16SELL-11104.250107.230 106.932GBX -1,176 161.71 Profit of 603 on sale
2025-04-15BUY11105.920107.580 107.414GBX 1,182 162.39
2025-04-14BUY22106.600107.670 107.563GBX 2,366 163.08
2025-04-11BUY3399.750101.360 101.199GBX 3,340 163.83
2025-04-09BUY11139.070139.310 139.286GBX 1,532 164.99
2025-04-08BUY22123.610137.960 136.525GBX 3,004 165.53
2025-04-07SELL-11134.070139.160 138.651GBX -1,525 165.98 Profit of 301 on sale
2025-04-04SELL-66136.900140.150 139.825GBX -9,228 166.42 Profit of 1,755 on sale
2025-04-01SELL-22145.990151.370 150.832GBX -3,318 167.08 Profit of 357 on sale
2025-03-31SELL-22150.520153.820 153.490GBX -3,377 167.38 Profit of 306 on sale
2025-03-28SELL-22155.550158.710 158.394GBX -3,485 167.64 Profit of 204 on sale
2025-03-25BUY11161.350168.000 167.335GBX 1,841 168.34
2025-03-21SELL-44167.280167.940 167.874GBX -7,386 168.66 Profit of 35 on sale
2025-03-20SELL-33165.350171.710 171.074GBX -5,645 168.85 Loss of -73 on sale
2025-03-18BUY66176.940177.120 177.102GBX 11,689 169.05
2025-03-11SELL-11166.630175.070 174.226GBX -1,916 169.89 Loss of -48 on sale
2025-03-10SELL-33175.120181.440 180.808GBX -5,967 170.00 Loss of -357 on sale
2025-03-07SELL-77175.920177.240 177.108GBX -13,637 170.11 Loss of -539 on sale
2025-03-05SELL-33167.550167.990 167.946GBX -5,542 170.31 Profit of 78 on sale
2025-03-03SELL-44163.500166.720 166.398GBX -7,322 170.70 Profit of 189 on sale
2025-02-27SELL-11164.880167.960 167.652GBX -1,844 171.05 Profit of 37 on sale
2025-02-19BUY11165.000166.440 166.296GBX 1,829 172.23
2025-02-18BUY22154.390155.690 155.560GBX 3,422 172.62
2025-02-13BUY22153.170155.290 155.078GBX 3,412 173.97
2025-02-05SELL-88165.870166.120 166.095GBX -14,616 176.06 Profit of 877 on sale
2025-02-04BUY11163.120169.670 169.015GBX 1,859 176.42
2025-01-29BUY11161.640163.000 162.864GBX 1,792 177.98
2025-01-28BUY11163.640167.470 167.087GBX 1,838 178.42
2025-01-24BUY33164.970168.150 167.832GBX 5,538 179.33
2025-01-23BUY77166.860169.010 168.795GBX 12,997 179.75
2025-01-22BUY55168.220170.830 170.569GBX 9,381 180.17
2025-01-21BUY11169.810171.750 171.556GBX 1,887 180.56
2025-01-16BUY66165.800168.620 168.338GBX 11,110 182.18
2025-01-15BUY11173.910182.250 181.416GBX 1,996 182.53
2025-01-10BUY11186.120188.260 188.046GBX 2,069 182.71
2024-12-10BUY11197.050202.720 202.153GBX 2,224 182.58
2024-12-09BUY44201.750202.570 202.488GBX 8,909 182.33
2024-12-05SELL-22191.540198.830 198.101GBX -4,358 182.39 Loss of -346 on sale
2024-12-04BUY33199.350201.420 201.213GBX 6,640 182.16
2024-12-03SELL-55199.300201.120 200.938GBX -11,052 181.89 Loss of -1,047 on sale
2024-12-02BUY22201.250203.010 202.834GBX 4,462 181.51
2024-11-25BUY22201.300202.870 202.713GBX 4,460 179.72
2024-11-22SELL-11195.770198.180 197.939GBX -2,177 179.32 Loss of -205 on sale
2024-11-21SELL-11194.190194.880 194.811GBX -2,143 179.05 Loss of -173 on sale
2024-11-18BUY55187.500187.930 187.887GBX 10,334 179.37
2024-11-12BUY11215.940221.600 221.034GBX 2,431 177.86
2024-11-08BUY77215.390216.150 216.074GBX 16,638 174.15
2024-11-07BUY22210.290217.600 216.869GBX 4,771 172.59
2024-11-06BUY11214.200230.020 228.438GBX 2,513 170.35
2024-10-31BUY33178.580181.230 180.965GBX 5,972 171.55
2024-10-29BUY11184.000186.460 186.214GBX 2,048 172.50
2024-10-28BUY11186.520188.000 187.852GBX 2,066 172.52
2024-10-25BUY11182.120184.550 184.307GBX 2,027 173.61
2024-10-24BUY11182.730186.320 185.961GBX 2,046 175.07
2024-10-23SELL-22186.630188.060 187.917GBX -4,134 176.01 Loss of -262 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CRL

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1998,1391131,07574.9%
2025-09-1862,9972121,43651.9%
2025-09-1792,1290727,00512.7%
2025-09-16115,39612317,67336.3%
2025-09-1566,3561151,09343.9%
2025-09-1277,5570176,81743.9%
2025-09-1187,9991204,23743.1%
2025-09-10122,6560398,56430.8%
2025-09-09125,4020471,64226.6%
2025-09-08178,3420414,72943.0%
2025-09-0576,2640192,66839.6%
2025-09-0494,7920179,53352.8%
2025-09-03139,6460216,26564.6%
2025-09-02112,81930183,91061.3%
2025-08-29105,9651,040180,20658.8%
2025-08-28183,9714248,97873.9%
2025-08-2771,8910134,03453.6%
2025-08-26109,85319166,15266.1%
2025-08-25147,16623300,78148.9%
2025-08-22251,1260414,08560.6%
2025-08-21102,1520149,37668.4%
2025-08-20152,7210215,94670.7%
2025-08-19118,8310172,88768.7%
2025-08-1893,0280164,64156.5%
2025-08-1596,5001180,16553.6%
2025-08-14147,9520251,45658.8%
2025-08-13820,20601,075,15376.3%
2025-08-12299,3220438,69968.2%
2025-08-11192,9170365,05852.8%
2025-08-0892,08966222,12841.5%
2025-08-07326,647522550,23059.4%
2025-08-06532,4347,827888,87359.9%
2025-08-05283,1486539,93852.4%
2025-08-04124,11154248,83449.9%
2025-08-01162,441300281,62257.7%
2025-07-31125,6480228,70654.9%
2025-07-30115,4870188,12161.4%
2025-07-29181,1590275,84365.7%
2025-07-28198,89649321,94161.8%
2025-07-25162,642111293,83155.4%
2025-07-24385,658456820,47247.0%
2025-07-23150,6500346,02043.5%
2025-07-22205,73626821,85325.0%
2025-07-21132,794101445,92029.8%
2025-07-1893,150207186,54249.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.


Copyright Market Footprint Ltd. Privacy Policy